Literature DB >> 30063476

Health-Related Quality of Life in Mandarin-Speaking Children With Cochlear Implants.

Yawen Zhao1,2, Ying Li2, Zhipeng Zheng2, Jing Li2, Xiaolu Nie3, Xin Jin2, Jun Zheng4, Jie Zhang2, Min Chen2, Jinsheng Hao2, Yang Yang2, Wei Liu2, Haihong Liu1,2, Xin Ni1,2.   

Abstract

OBJECTIVES: The primary aim of this study was to evaluate the health-related quality of life (HRQoL) of children with cochlear implants (CIs) from the parental perspective. The secondary objective was to explore possible relationships between demographic variables (such as age at assessment, gender, age at implantation, and duration of language rehabilitation) and the HRQoL. The third objective was to determine the developmental trajectories of HRQoL.
DESIGN: This study included parents of 123 children with CIs (mean age, 40.45 months; mean age of CI implantation, 24.74 months; mean device experience, 16.34 months). The time periods for follow-up were at 0, 1, 2, 3, 6, and 12-month intervals of CI use. The Mandarin Children with Cochlear Implants: Parental Perspectives questionnaire was employed to assess HRQoL.
RESULTS: Parents were satisfied with HRQoL, especially with the domain of social relations; however, education received a less positive rating. The duration of CI use was positively correlated with 5 domains, suggesting that children who used CIs for a longer time had higher HRQoL ratings. Children with longer language rehabilitation received more positive ratings in the domains of social relations and education (p < 0.05); children whose mothers had higher education levels received more positive ratings in the domain of general functioning (p < 0.05); children living in cities received more positive ratings in the domains of communication, general functioning and self-reliance (p < 0.05). Girls received more positive rating than boys in the domain of well-being (p < 0.05). No significant correlation was found between age at implantation, age at assessment, only child status, and HRQoL. All domains showed clear increases in the duration of CI use; the majority of the domains showed steeper progress over the first 3 months of CI use. Communication exhibited the most rapid progress, with education progressing at a slower rate.
CONCLUSIONS: Parents were satisfied with all domains of HRQoL. Almost all domains exhibited rapid progress over the first 3 months of CI use, with education progressing at a slower rate. This research underscores the importance of language rehabilitation by revealing that strengthening language rehabilitation could be an effective means of improving the HRQoL of children with CIs.

Entities:  

Year:  2019        PMID: 30063476     DOI: 10.1097/AUD.0000000000000633

Source DB:  PubMed          Journal:  Ear Hear        ISSN: 0196-0202            Impact factor:   3.570


  5 in total

1.  AAV-Mediated Neurotrophin Gene Therapy Promotes Improved Survival of Cochlear Spiral Ganglion Neurons in Neonatally Deafened Cats: Comparison of AAV2-hBDNF and AAV5-hGDNF.

Authors:  Patricia A Leake; Stephen J Rebscher; Chantale Dore'; Omar Akil
Journal:  J Assoc Res Otolaryngol       Date:  2019-06-20

2.  Restricted Speech Recognition in Noise and Quality of Life of Hearing-Impaired Children and Adolescents With Cochlear Implants - Need for Studies Addressing This Topic With Valid Pediatric Quality of Life Instruments.

Authors:  Maria Huber; Clara Havas
Journal:  Front Psychol       Date:  2019-09-12

3.  Quality of life in children with cochlear implants in Kazakhstan.

Authors:  Ruslan Zhumabayev; Galiya Zhumabayeva; Gulnara Kapanova; Nailya Tulepbekova; Anuar Akhmetzhan; Andrej Grjibovski
Journal:  BMC Pediatr       Date:  2022-04-11       Impact factor: 2.125

Review 4.  Neurotrophin gene therapy to promote survival of spiral ganglion neurons after deafness.

Authors:  Patricia A Leake; Omar Akil; Hainan Lang
Journal:  Hear Res       Date:  2020-04-05       Impact factor: 3.208

5.  Health-related quality of life in children who use cochlear implants or hearing aids.

Authors:  Olga María Alegre-de la Rosa; Luis Miguel Villar-Angulo
Journal:  Heliyon       Date:  2020-01-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.